Thank you, Craig, and good morning, everyone. Total revenue for fiscal 2026 was $20.1 million, an increase of 85% from $10.9 million in fiscal 2025. Commission revenue increased 56% to $9.3 million from $5.9 million. Stock locate fees increased to $6.8 million from roughly $300,000. Clearing fees were $2.1 million compared to $3.2 million in fiscal 2025. This line includes both the fees we charge our clearing correspondent and customer account service fees and the prior year benefited from 2 unusually large months of service fee revenue. Importantly, revenue from our existing correspondent increased approximately 67% to $1.4 million, and the 6 new correspondents we have signed did not contribute meaningfully to fiscal 2026 results. Vetting fees were $1.4 million, broadly consistent with $1.5 million a year ago. Net gains on firm trading accounts increased to over $500,000 from under $7,000 and other revenue was approximately $65,000. Total expenses were $29.8 million compared with $15.8 million for fiscal 2025. Compensation, payroll taxes and benefits increased 91% to $11.7 million from $6.2 million, primarily because of higher variable compensation associated with revenue growth. Separately, we recorded $3.6 million in noncash stock-based compensation related to executive employment agreements entered into in September 2025 with no comparable expense in fiscal 2025. Data processing and clearing costs increased 98% to $4.2 million from $2.1 million, generally in line with the higher level of activity. We also recorded $800,000 of stock locate expense and $700,000 of Loanet expense, both new cost categories associated with the growth of the stock locate business. Regulatory professional and related expenses increased 17% to $4.9 million from $4.1 million, primarily reflecting professional fees related to the Commercial Bancorp negotiations and additional consulting support. The resulting loss from operations was $9.8 million compared to $4.9 million in fiscal 2025. The increase primarily reflected the variable costs associated with higher business activity and the $3.6 million noncash stock-based compensation charge. These expenses supported a business that generated 85% revenue growth and rapidly expanded newer revenue lines during the year. Below the operating line, total other income was $11.5 million compared to $10.4 million a year ago. The principal items included noncash gains of $11.1 million from the change in fair value of our earn-out liability, $1.8 million related to the Winston & Strawn agreement, $1.7 million from the change in fair value of warrant liabilities and $400,000 from the change in fair value of our convertible note derivative. These gains were partially offset by $5.1 million in interest expense and a $570,000 loss on settlement of the Winston & Strawn agreement. Income before taxes was $1.7 million. After a tax benefit of $250,000 net income was $2 million or $0.02 per basic and diluted share based on weighted average shares outstanding of approximately 125 million. This compares with net income of $5.8 million or $0.96 per share in fiscal 2025. The prior year result included a $12.4 million noncash gain from changes in the fair value of the long-term and short-term note derivatives. Turning to the balance sheet. We ended the year with cash and cash equivalents of $15.4 million, more than double the $7.5 million reported a year earlier. Total assets increased to $71.2 million from $60.9 million. Stockholders' equity improved to $21.1 million from stockholders' deficit of $6.8 million, while the total liabilities declined by approximately $17.6 million. Shares outstanding were approximately 150.3 million at fiscal year-end and approximately 151.8 million as of the date specified in the Form 10-K. Cash used in operating activities was $6.2 million compared with cash provided by operating activities of $800,000 in fiscal 2025. The change reflected growth in operating assets as the business expanded as well as the noncash nature of a substantial portion of fiscal 2026 net income. Cash used in investing activities was $65,000, representing a payment related to the extension of the Commercial Bancorp acquisition agreement. Cash provided by financing activities was $16.5 million compared to $1.6 million in fiscal 2025, driven primarily by the financing transactions completed during the year and partially offset by transaction costs, repayments and the $1 million cash payment related to the Winston & Strawn settlement. Finally, Atlas Clearing's $10 million revolving line of credit with BMO Harris Bank remained undrawn throughout the year, and the company was in compliance with all applicable financial covenants as of June 30, 2026. Based on the capital raised and management's operating cash flow forecast, management concluded that substantial doubt about the company's ability to continue as a going concern have been alleviated. Management also concluded that disclosure controls and internal control over financial reporting were effective as of June 30, 2026, following the remediation of the previously reported material weakness. I will now turn the call back to John for closing remarks before we open the line for questions. John?